Your browser doesn't support javascript.
[Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19].
Zhang, J; Peng, P; Li, X; Zha, Y F; Xiang, Y; Zhang, G N; Zhang, Y.
  • Zhang J; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Peng P; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Li X; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Zha YF; Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Xiang Y; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Zhang GN; Department of Gynecologic Oncology, Sichuan Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
  • Zhang Y; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zhonghua Fu Chan Ke Za Zhi ; 55(4): 221-226, 2020 Apr 25.
Article in Chinese | MEDLINE | ID: covidwho-8634
ABSTRACT

Objective:

To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID-19.

Methods:

We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID-19 in Renmin Hospital of Wuhan University, and proposed management strategies for patients with gynecological tumors underriskof COVID-19.

Results:

Based on the national diagnosis and treatment protocol as well as research progress for COVID-19, three patients with COVID-19 were treated. Meanwhile, they were also appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19.

Conclusions:

Patients with gynecological malignant tumors are high-risk groups prone to COVID-19, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While, actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Genital Neoplasms, Female Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Female / Humans Language: Chinese Journal: Zhonghua Fu Chan Ke Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.cn112141-20200302-00168

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Genital Neoplasms, Female Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Female / Humans Language: Chinese Journal: Zhonghua Fu Chan Ke Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.cn112141-20200302-00168